Cite

HARVARD Citation

    Choi, W. et al. (2019). Immunogenicity and safety of a new live attenuated herpes zoster vaccine (NBP608) compared to Zostavax® in healthy adults aged 50 years and older. Vaccine. 37 (27), pp. 3605-3610. [Online]. 
  
Back to record